You justify a valuation by showing that the number follows from evidence an investor can check: a method that fits your stage, inputs you can source, a range rather than a single figure, and a clear answer for each question a partner will raise. Investors rarely accept or reject the number itself. They test the reasoning behind it, and the weakest assumption in that reasoning is where the negotiation happens. At Dialectic, we built our platform for that moment: you upload your deck or memo and it is scrutinized the way a skeptical VC partner would scrutinize it, before the real meeting.
TL;DR
- A valuation is a negotiated estimate, not a formula result. Defend the reasoning, the range and the inputs, not one magic figure.
- Match the method to your stage: qualitative methods before revenue, comparables and revenue multiples once you have revenue.
- Pre-money and post-money determine how much of the company you sell. Do the dilution math before the meeting.
- When an investor pushes back, bring specifics, use more than one method and read the whole term sheet, not just the headline price.
- Rehearse the hardest questions out loud. Weak assumptions are cheaper to find in practice than in the room.
Table of Contents
- What investors mean by valuation
- Do the ownership math before anyone asks
- Pick a method that fits your stage
- Build a range, not a single number
- Use evidence, not adjectives
- What investors will probe
- When an investor pushes back or offers less
- A short worked example
- Stress-test the case before the meeting
- Where Dialectic fits
- Our perspective
- FAQ
- Sources
What investors mean by valuation
Valuation is the price tag on the company that sets the price of each share an investor buys. The Holloway Guide describes it as a negotiated estimate. With the investment amount fixed, a higher valuation generally means you sell a smaller percentage of the company.
That is why investors care about it so much, and why “justify” is the right word. You are not announcing what the company is worth. You are persuading a person who has seen hundreds of decks that the price is fair for the risk they take, and that it still leaves them a path to a strong return.
Two terms come up in every conversation:
- Pre-money valuation is the company’s value before the new money goes in.
- Post-money valuation is the value after the investment. It equals pre-money plus the amount raised.
Wilson Sonsini’s guide to negotiating US VC term sheets defines both the same way. If you mix them up in front of an investor, the rest of your argument loses credibility fast.
Do the ownership math before anyone asks
The fastest way to sound like you understand your own round is to know what each number does to your cap table. Here are three worked examples from published sources:
| Pre-money | Raise | Post-money | Result | Source |
|---|---|---|---|---|
| $2,000,000 | $500,000 | $2,500,000 | Investor owns 20% | DigitalOcean |
| $3,000,000 | $2,000,000 | $5,000,000 | Investors own 40% | Wilson Sonsini |
| $5,000,000 | $1,000,000 | $6,000,000 | Existing holders diluted by 16.67% | Holloway Guide |
The formula is simple: the investor’s ownership equals the investment divided by the post-money valuation. Know this cold. When an investor says “we need 20% for this check,” you can immediately say what pre-money that implies and whether you can live with it.
It also helps you see the investor’s side. The Forbes Finance Council piece points out that a fund may reject a price that falls outside its check size and ownership requirements, and its example is a firm seeking a $5 million check for a 20% stake. A strong company can still be outside a particular fund’s range. Sometimes the pushback is about the fund’s math, not your business.
Pick a method that fits your stage
Investors discount a valuation quickly when the method does not suit the company. A pre-revenue startup defended with a discounted cash flow model invites the obvious question: where do those cash flows come from?
The UC San Diego startup toolkit notes that forecasts are hard at pre-revenue stages, so early valuations require judgment rather than treating projections as certainty. Say that openly. Investors respect a founder who knows what the numbers can and cannot support.
Ramp’s valuation guide lays out which approaches tend to fit which stage:
- Pre-revenue: Berkus, scorecard, risk-factor summation and cost-to-duplicate. These are qualitative, and they price the team, the product, the market and the risk.
- With revenue: comparable-company analysis, revenue multiples and the VC method. Growth, retention and market position matter here.
- Later stage: discounted cash flow, EBITDA multiples and precedent transactions, which need reliable financial data and forecasts.
Comparable companies
The Investor Connect valuation Q&A describes comparable-company analysis as comparing businesses at similar stages, in similar sectors and with similar business models, using their financing or exit values as reference points. The strength of your argument depends on how honest the comparison set is. If every comp is two years older with five times your revenue, an investor will say so within a minute.
Revenue multiples
The New York Angels guide explains that a revenue multiple is applied to the prior 12 months of revenue, and that the multiple reflects expected future growth and profit. Its illustration is a B2B SaaS company valued at $10 million at a 10x multiple. That does not mean $1 million in sales is worth $10 million. The appropriate multiple depends on growth, margins, sector economics, scalability and risk. Your job is to show why your multiple belongs at the high end of the range, not just to quote it.

Build a range, not a single number
A single figure invites a single objection. A range, with the reasoning for each end, turns the conversation into a discussion about assumptions.
A practical way to build one:
- Run two or three methods that fit your stage. Different methods surface different assumptions and risks. Where they agree, you have a strong anchor. Where they diverge, you know which assumption to defend.
- Write down each method’s inputs. For each one, note the comparable set, the multiple, the growth rate and the date of the benchmark. An input with no source and no date is the first thing a partner will attack.
- Set a low, a target and a high case. Be able to say what has to be true for each.
- Check the target against your plan. Does the round fund you to the next milestone? Will the valuation leave room for the next round to be an up-round? A price that looks great today but forces a flat or down round later is a weaker position than it appears.
The Investor Connect Q&A advises founders to know the approximate market range and the method used, and notes that using multiple methods helps show where estimates converge or diverge when an investor challenges the number.
Use evidence, not adjectives
“We are in a huge market with a world-class team” is not evidence. An investor needs something to point to when they take your number to their partners.
The New York Angels guide says a founder with little or no revenue can support the case with non-revenue traction, such as growing usage, serious conversations with major customers or progress on distribution, and should explain how each of these turns into revenue. Strong proof points include:
- Revenue growth with the period stated. A suggested script in the Forbes Finance Council article ties the valuation to progress such as doubling revenue and expanding into two markets.
- Retention or repeat usage, if you have it.
- Pipeline or signed pilots, described with names where you can share them and with conversion rates where you cannot.
- Unit economics that hold up under questioning. Our guide on answering investor questions on unit economics covers how those questions are asked.
- A market size built from the bottom up. See how to handle market size questions.
Every piece of evidence should connect back to the price: this progress, at this stage, in this market, is why the number is reasonable. If a slide cannot be tied to the valuation, it is decoration.
What investors will probe
When a partner challenges a valuation, they seldom say “your valuation is wrong.” They ask about the assumptions that hold it up. Expect questions like these:
- Why that multiple, and why those comparables?
- What happens to the numbers if growth is half of your forecast?
- How much of the revenue is repeatable?
- Who else can do this, and what stops them from doing it cheaper?
- What does the money buy, and what will be true in 18 months?
The weak spots tend to be the same ones: soft comparables, a market size that is just a big top-down number, unit economics that are not yet proven, and a competition slide that says there is none. Our guides on competition questions and red flags investors notice early go through them. For pre-seed founders, the first-meeting questions VCs ask show how soon valuation logic gets tested.
When an investor pushes back or offers less
A lower offer is not automatically a verdict on your business. It can reflect the investor’s own ownership target, their check size, or a different read on risk. Here is how to respond.
Ask what is driving the number
Is it the method, a specific assumption, the comparables or the fund’s math? You cannot answer an objection you have not located. Investor Connect’s guidance is to bring the specifics and inputs behind your valuation and to treat the final price as a negotiation rather than a formula’s output.
Defend the input, not the ego
If the investor says your growth forecast is too aggressive, show the data that supports it and what you would conclude if it were lower. Conceding a weak assumption early, while holding firm on strong ones, makes the strong ones more believable.
Read the whole term sheet
The headline price is only one term. Wilson Sonsini’s guide cautions that a high valuation can come with unfavorable control or capitalization terms and can hurt employee incentives. A slightly lower valuation with cleaner terms can leave you better off than a high one with strings attached. Have your startup counsel review any term sheet before you sign it.
Know when it is a fit problem
If the valuation you need sits outside a fund’s range, no argument will fix it. Better to learn that in the first meeting and move to investors whose check size and ownership targets match your round.
A short worked example
Say you are a B2B SaaS founder with $1 million in annual recurring revenue, growing steadily, raising $2 million.
- You apply a revenue multiple range, then compare it to a handful of companies at a similar stage and model.
- You cross-check it against ownership: at a $8 million pre-money valuation, the $2 million raise gives a $10 million post-money and the investor 20%. At $6 million pre-money, post-money is $8 million and the investor owns 25%.
- You note what has to be true for the high end: your growth rate, your retention and why your sector deserves a premium.
- You prepare for the partner who says the comps are better-funded and older, and for the one who asks what happens if growth halves.
That is a justification. Not “we think we are worth $8 million,” but “here is how we got to the range, here is where we sit in it and why, and here is what would change our view.” The figures are illustrative; the structure is what to copy.
Stress-test the case before the meeting
Reading about objections is not the same as answering them live. A valuation argument often falls apart at the second follow-up question, when a founder who rehearsed only the opening has nothing left.
The useful rehearsal is adversarial. A supportive reviewer who tells you the deck looks great does not help you find the fragile assumption in your revenue multiple. What helps is a reviewer who asks what happens when it is wrong. Our guide on the pitch deck red team explains the approach, and the last-minute pitch checklist helps when the meeting is close.
Where Dialectic fits
You upload your pitch deck or memo to Dialectic, and it puts it through expert-style scrutiny built around the questions VCs ask when they want to find the flaw. You get fragility and risk scoring and a structured list of weaknesses and blind spots, with actionable feedback on how to fix them. That includes the assumptions underneath your valuation story: growth, market size, unit economics and competition.
Then you can practice the defense. Boardroom rehearsal is a real-time session in which you answer tough investor questions out loud and your defense is graded. You can read how it works in our guide to boardroom rehearsal.
The options:
- Tactical Audit: $25 one-off per audit, for one deck or memo before one meeting.
- Founder Pro: $49 per month, for founders iterating through a fundraise.
- Venture & Studio 5 Seats: $149 per month, for teams and studios with several people pitching.
Upload your deck on the Dialectic site and find where your valuation story is weakest before an investor does.

Our perspective
Most founders prepare a valuation the way they prepare a slide: they pick a number, find a few supportive comps and hope nobody pushes. Investors push for a living.
We built Dialectic around that gap. Standard AI feedback tends to be supportive, and supportive feedback is not what a partner delivers. A partner looks for the fragile assumption, the blind spot and the question you hoped would not come up. Our platform applies that adversarial, partner-style scrutiny to your deck or memo, scores its fragility, and shows you where the argument breaks.
A valuation is only as strong as the weakest claim holding it up. Finding that claim in a rehearsal, and practicing the answer in a graded boardroom session, is how a founder walks into the meeting ready for the real conversation instead of a polite one.
D
FAQ
How do I justify a valuation with no revenue?
Use qualitative methods such as Berkus, scorecard or risk-factor summation, and support them with traction that is not revenue: growing usage, serious customer conversations and distribution progress. Explain how each of these turns into revenue. Be open that early valuations rest on judgment rather than precise forecasts.
How much is a business worth with $1 million in sales?
There is no universal answer. The New York Angels guide illustrates a B2B SaaS company valued at $10 million at a 10x revenue multiple, but the right multiple depends on growth, margins, sector economics, scalability and risk. Justify your multiple with data on those factors rather than quoting an average.
What should I do if an investor says my valuation is too high?
Find out whether the objection is about your method, one specific assumption or their fund’s ownership target. Then answer with the inputs behind your number, show where several methods agree, and treat the price as a negotiation. Compare any lower offer on the full term sheet, not only the headline figure.
Should I give one valuation number or a range?
Prepare a range with low, target and high cases and the reasoning for each, and be ready to say what has to be true at each point. A range shows you understand what drives the number, and it gives you room to negotiate without appearing to retreat.
Sources
- A Primer on Ownership, The Holloway Guide to Raising Venture Capital
- 5 Tips for Negotiating Term Sheets with US VC Investors, Wilson Sonsini
- Pre-money valuation explained, DigitalOcean
- Startup Valuation: How To Confidently Navigate Investor Discussions, Forbes Finance Council
- How to Value an Early Stage Company, UC San Diego startup toolkit
- Startup Valuation Methods: A Complete Guide, Ramp
- Setting Valuation Q&A transcript, Investor Connect
- How to Value Your Startup, New York Angels

Leave a Reply